BIOMAT Database Logo BIOMAT Database Logo

Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen. 1990

A Utani, and T Tanaka, and C Nishigori, and Y Miyachi, and K Danno, and S Imamura, and M Hosokawa, and T Takeda, and K Hirayoshi, and K Nagata
Department of Dermatology, University School of Medicine, Kyoto University, Japan.

The nature of type III collagen was examined in the skin and cultured skin fibroblasts from a patient with Ehlers-Danlos syndrome type IV. Although the culture medium contained a much lower amount of Type III collagen than the controls, the cells contained an apparently normal amount of Type III collagen. The patient's Type III procollagen showed no abnormalities in apparent molecular weight, the peptide length as examined by cyanogen bromide cleavage, the genomic DNA size including its C- and N-propeptide portion, mRNA size, or thermal stability; but a pulse-chase study revealed prolonged retention of the type III collagen in the cells. Degradation of Type III procollagen was induced by cell extracts but did not occur in the extracellular space and was inhibited in intact cells by the addition of ammonium chloride or leupeptin to the culture medium. Fluorescent staining showed a characteristic granular deposition of Type III procollagen in the peripheral region of the cytoplasm but no granular deposition of Type I procollagen. These results offer new insight into the mechanism of the decreased amount of Type III collagen in the tissue of patients with Ehlers-Danlos syndrome type IV.

UI MeSH Term Description Entries
D007976 Leupeptins A group of acylated oligopeptides produced by Actinomycetes that function as protease inhibitors. They have been known to inhibit to varying degrees trypsin, plasmin, KALLIKREINS, papain and the cathepsins.
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011347 Procollagen A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains. Protocollagen,Procollagen Type M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D004535 Ehlers-Danlos Syndrome A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability. Cutis Elastica,Ehlers Danlos Disease,Ehlers-Danlos Disease,Danlos Disease, Ehlers,Disease, Ehlers Danlos,Disease, Ehlers-Danlos,Ehlers Danlos Syndrome,Syndrome, Ehlers-Danlos
D005110 Extracellular Space Interstitial space between cells, occupied by INTERSTITIAL FLUID as well as amorphous and fibrous substances. For organisms with a CELL WALL, the extracellular space includes everything outside of the CELL MEMBRANE including the PERIPLASM and the cell wall. Intercellular Space,Extracellular Spaces,Intercellular Spaces,Space, Extracellular,Space, Intercellular,Spaces, Extracellular,Spaces, Intercellular
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein

Related Publications

A Utani, and T Tanaka, and C Nishigori, and Y Miyachi, and K Danno, and S Imamura, and M Hosokawa, and T Takeda, and K Hirayoshi, and K Nagata
Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen.
November 1984, American journal of medical genetics,
A Utani, and T Tanaka, and C Nishigori, and Y Miyachi, and K Danno, and S Imamura, and M Hosokawa, and T Takeda, and K Hirayoshi, and K Nagata
Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV.
May 1989, Human genetics,
A Utani, and T Tanaka, and C Nishigori, and Y Miyachi, and K Danno, and S Imamura, and M Hosokawa, and T Takeda, and K Hirayoshi, and K Nagata
Type III collagen deficiency and type IV Ehlers-Danlos syndrome.
March 1988, Journal of neurosurgery,
A Utani, and T Tanaka, and C Nishigori, and Y Miyachi, and K Danno, and S Imamura, and M Hosokawa, and T Takeda, and K Hirayoshi, and K Nagata
Patients with Ehlers-Danlos syndrome type IV lack type III collagen.
April 1975, Proceedings of the National Academy of Sciences of the United States of America,
A Utani, and T Tanaka, and C Nishigori, and Y Miyachi, and K Danno, and S Imamura, and M Hosokawa, and T Takeda, and K Hirayoshi, and K Nagata
Substitution of valine for glycine 793 in type III procollagen in Ehlers-Danlos syndrome type IV.
January 1995, Human mutation,
A Utani, and T Tanaka, and C Nishigori, and Y Miyachi, and K Danno, and S Imamura, and M Hosokawa, and T Takeda, and K Hirayoshi, and K Nagata
[The Ehlers-Danlos syndrome type III and type IV].
January 2007, Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina),
A Utani, and T Tanaka, and C Nishigori, and Y Miyachi, and K Danno, and S Imamura, and M Hosokawa, and T Takeda, and K Hirayoshi, and K Nagata
Aberrant splicing of the type III procollagen mRNA leads to intracellular degradation of the protein in a patient with Ehlers-Danlos type IV.
January 1995, Human mutation,
A Utani, and T Tanaka, and C Nishigori, and Y Miyachi, and K Danno, and S Imamura, and M Hosokawa, and T Takeda, and K Hirayoshi, and K Nagata
Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
November 2001, American journal of human genetics,
A Utani, and T Tanaka, and C Nishigori, and Y Miyachi, and K Danno, and S Imamura, and M Hosokawa, and T Takeda, and K Hirayoshi, and K Nagata
Type III collagen mutations in Ehlers Danlos syndrome type IV and other related disorders.
September 1988, Clinical and experimental dermatology,
A Utani, and T Tanaka, and C Nishigori, and Y Miyachi, and K Danno, and S Imamura, and M Hosokawa, and T Takeda, and K Hirayoshi, and K Nagata
Ehlers-Danlos syndrome type IV: cosegregation of the phenotype to a COL3A1 allele of type III procollagen.
September 1986, Human genetics,
Copied contents to your clipboard!